Compare · AMED vs EUDA
AMED vs EUDA
Side-by-side comparison of Amedisys Inc (AMED) and EUDA Health Holdings Limited (EUDA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMED and EUDA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- AMED is the larger of the two at $4.20B, about 97.5x EUDA ($43.1M).
- EUDA has hit the wire 2 times in the past 4 weeks while AMED has been quiet.
- AMED has more recent analyst coverage (25 ratings vs 0 for EUDA).
- Company
- Amedisys Inc
- EUDA Health Holdings Limited
- Price
- -
- -
- Market cap
- $4.20B
- $43.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 2
- Recent ratings
- 25
- 0
Amedisys Inc
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. As of December 31, 2020, the company owned and operated 320 home health care centers, 180 hospice care centers, and 14 personal-care care centers in 39 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Latest AMED
- SEC Form 15-12G filed by Amedisys Inc
- Twilio Set to Join S&P MidCap 400
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
Latest EUDA
- SEC Form 424B3 filed by EUDA Health Holdings Limited
- SEC Form EFFECT filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
- SEC Form 424B5 filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited